Barry Bannister, Stifel chief equity strategist, joins 'Power Lunch' to discuss the bad signs for the market and the DeepSeek ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...

Fintel reports that on January 27, 2025, Stifel upgraded their outlook for Portillo's (NasdaqGS:PTLO) from Hold to Buy.

Some "value sectors" may outperform this year, said Gordon. As long as the labor market and economy remain strong, that "creates solid ground for value to catch back up to growth," he said, after ...

In this Market Factors, we cover one strategist’s view that Monday’s market volatility is just the beginning. A BofA report ...

We recently published a list of 10 Stocks That Analysts Are Talking About. In this article, we are going to take a look at ...

Stifel analyst Chris O’Cull upgraded Portillo’s (PTLO) to Buy from Hold with a price target of $16, up from $13. The firm previously downgraded ...

The S&P 500, a gauge of U.S. large-cap stocks, notched a record closing high of 6,118.71 on Jan. 23, according to Dow Jones Market Data. Big Tech stocks have massive market values, translating into ...

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

XPO Inc (XPO) stock saw a modest uptick, ending the day at $139.1 which represents a slight increase of $0.09 or 0.06% from the prior close of $139.01. The stock opened at $138.64 and touched a low of ...